Why is India’s Contribution Important To The World Pharmaceutical Landscape?

[mstakh.i.mo.mi]

India is also referred to as the “Pharmacy of the World” due to Indian pharmaceutical industry’s low cost and good quality primary USPs.

In 2019–20, the Indian pharmaceutical industry’s total yearly revenue was $36.7 billion, with the availability of inexpensive HIV medications among the greatest successes. In 2021, it reached $42 billion. A further rise is expected in the coming years with the anticipation that the annual revenue of the Indian pharmaceutical industry will reach $120 billion in 2030. Furthermore, India is one of the biggest exporters of affordable vaccines. Most medicines exported from India today are drug formulations and biologicals, which make up around 75% of all exports.


India is the biggest contributor to the pharmaceutical industry. Here’s how.

India’s export medicines are targeted to the Middle East, Asia, CIS, Latin America, and the Caribbean (LAC), North America, Africa, the EU, ASEAN, and other European regions.
Africa, Europe, and NAFTA receive almost two-thirds of India’s export of greece phone number list medicines. In 2021–22, the USA, the UK, South Africa, Russia, and Nigeria were five of India’s top export markets for pharmaceutical products.
Do you know which countries import medicines from India? The United States is the largest importer of Indian medicines. United Kingdom, Brazil, South Africa, Venezula and Russia are among the top importers from India. Around 200 countries across the globe import medicines from India.
In FY21–22, India exported medicines to nations like the USA ($7,101,6 million), the UK ($704,5 million), South Africa ($612,3 million), Russia ($597,8 million), and Nigeria ($588.6 million).
Over the past three years, the value of India’s pharmaceutical exports to the USA increased at a CAGR of 6.9%. Additionally, over the same period, it increased at a CAGR of 3.8% for the UK and 7.2% for Russia, respectively.
These statistics show why India is a key player in the global pharmaceutical industry.